SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-012510
Filing Date
2021-03-11
Accepted
2021-03-11 16:11:14
Documents
60
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K evok-10k_20201231.htm 10-K 1733261
2 EX-10.30 evok-ex1030_158.htm EX-10.30 34504
3 EX-10.32 evok-ex1032_589.htm EX-10.32 32242
4 EX-23.1 evok-ex231_7.htm EX-23.1 2876
5 EX-31.1 evok-ex311_6.htm EX-31.1 10245
6 EX-31.2 evok-ex312_10.htm EX-31.2 10772
7 EX-32.1 evok-ex321_9.htm EX-32.1 6651
8 EX-32.2 evok-ex322_8.htm EX-32.2 6720
9 GRAPHIC gvhlommmgus2000001.jpg GRAPHIC 58404
  Complete submission text file 0001564590-21-012510.txt   5557217

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT evok-20201231.xml EX-101.INS 869203
11 XBRL TAXONOMY EXTENSION SCHEMA evok-20201231.xsd EX-101.SCH 50740
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20201231_cal.xml EX-101.CAL 37382
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20201231_def.xml EX-101.DEF 162914
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20201231_lab.xml EX-101.LAB 394689
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20201231_pre.xml EX-101.PRE 291465
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36075 | Film No.: 21733396
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences